Fengyuan Pharmaceutical: An indicative announcement on the 2022 Restricted Stock Incentive Plan to lift the listing and circulation of restricted shares during the second lifting period

SZSI · Oct 16

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.